SCHEMBL27768149

SCHEMBL27768149

NCc1cccc(NC(=O)Nc2ccc(-c3cc(CN4CCOCC4)n4ncnc(N)c34)cc2Cl)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACVRL1 P37023 7/20 0.60
MERTK Q12866 1/20 0.47
NTRK2 Q16620 2/20 0.45
NTRK1 P04629 1/20 0.45
KDR P35968 5/20 0.42
KIT P10721 3/20 0.42
FLT3 P36888 3/20 0.42
TEK Q02763 1/20 0.41
RET P07949 1/20 0.40
BCR P11274 1/20 0.40
FGFR1 P11362 1/20 0.40
FRK P42685 1/20 0.40
MAPK9 P45984 1/20 0.40
RPS6KA3 P51812 1/20 0.40
PRKCD Q05655 1/20 0.40
DDR1 Q08345 1/20 0.40
MAP4K2 Q12851 1/20 0.40
TNK1 Q13470 1/20 0.40
RPS6KA1 Q15418 1/20 0.40
MAP3K11 Q16584 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL58299 0.92 ACVRL1 (0.62) ACVRL1MERTKNTRK2NTRK1KDR
SCHEMBL58575 0.91 ACVRL1 (0.60) ACVRL1MERTKNTRK2NTRK1KDR
SCHEMBL57964 0.91 ACVRL1 (0.60) ACVRL1MERTKNTRK2NTRK1KDR
Hydrochloric Acid SCHEMBL27768114 0.90 ACVRL1 (0.63) ACVRL1MERTKNTRK2NTRK1KDR
SCHEMBL59355 0.89 ACVRL1 (0.58) ACVRL1MERTKNTRK2NTRK1KDR
SCHEMBL59318 0.89 ACVRL1 (0.58) ACVRL1MERTKNTRK2NTRK1KDR
SCHEMBL27747161 0.89 ACVRL1 (0.60) ACVRL1MERTKNTRK2NTRK1KDR
SCHEMBL58540 0.86 ACVRL1 (0.57) ACVRL1MERTKKDRFLT3RET
SCHEMBL59409 0.85 ACVRL1 (0.55) ACVRL1MERTKKDRKITFLT3
SCHEMBL59260 0.85 ACVRL1 (0.57) ACVRL1MERTKNTRK2NTRK1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101466710-B Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER HEALTHCARE LLC 2013-05-29 CN disclosed
CN-101466710-A Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER HEALTHCARE LLC (US) 2009-06-24 CN disclosed